Taylor MH, Betts CB, Maloney L, Nadler E, et al. Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res 2021 Dec 3. pii: 1078-0432.CCR-21-2547.
PMID: 34862248